About 15 million Americans don’t have a typical nine-to-five workday, and many of these—nurses, firefighters and flight attendants, among many other professions—may see their schedule change drastically one week to the next. As a result, these shift workers’ biological clocks, which keep track of the time of day, cannot keep accurate time, potentially making the negative effects of a high fat diet on metabolic disorders even more pronounced, according to new research published in The FASEB Journal. Continue Reading…..
Chapkin is also a Distinguished Professor, Regents Professor and University Faculty Fellow in the Program in Integrative Nutrition and Complex Diseases, as well as a Texas A&M AgriLife Senior Faculty Fellow. He is a National Cancer Institute R35 Outstanding Investigator and is co-director of a National Institutes of Health-funded nutrition, biostatistics and bioinformatics training grant. [Read more…]
Dr. Alfredo Erazo-Oliveras, a postdoctoral research associate in Dr. Robert Chapkin’s laboratory (Program in Integrative Nutrition and Complex Diseases) at Texas A&M University, has been selected as an awardee in the Ford Foundation 2017 Postdoctoral Fellowship Competition.
Dr. Erazo-Oliveras selection for this prestigious award reflects the review panelists’ enthusiasm regarding his scholarly competence as well as the promise that he shows for future achievements as a scholar, researcher, and teacher. As part of the award beginning in June 2017, Dr. Erazo-Oliveras will receive a $45,000 stipend for one year as well as funds to attend the annual national Conference of Ford Fellows in San Juan, Puerto Rico on May 2018. Additionally, he will be granted access to Ford Fellow Regional Liaisons, a network of former Ford Fellows who have volunteered to provide mentoring and support to current fellows. [Read more…]
Webinar on lipids and oncology, presented by Dr. Catherine Field and Dr. Robert Chapkin, two of the world’s leading experts in the molecular mechanisms by which lipids modulate cancer risk and therapy. Together with DSM’s Dr. Keri Marshall, they will discuss the evidence for the use of lipids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), as a part of neoadjuvant therapy for two of the most common cancers: breast and colon. Click Here for Webinar.
An interdisciplinary team of researchers at Texas A&M University has been awarded a Division of Computing and Communication Foundations grant by the National Science Foundation to develop a gut-microbial investigation model that can identify critical dietary risk factors that cause colorectal cancer. The three-year, $350,000 project is a direct outcome of Texas A&M Engineering Experiment Station’s Interdisciplinary Seed Grants for Strategic Initiatives, which provided initial funding to establish the collaborative research effort. Continue Reading…